Hentapan, Angelita M.

HRN: 00-54-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/30/2026
07/04/2026
IV
1300mg
Q24hrs
Septic Encephalopathy
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: